Characteristics of Treated Asthmatics Experiencing Exacerbations in a US Database: A Retrospective Cohort Study

References

• Akinbami LJ, Moorman JE, Bailey C, et al. Trends in asthma prevalence, health care use, and mortality in the United States, 2001–2010. NCHS Data Brief. 2012;94:1–8.
   PubMedGoogle Scholar
• Enilari O, Sinha S. The global impact of asthma in adult populations. Ann Glob Health. 2019;85(1):2. doi:10.5334/aogh.2412
   PubMed Web of Science ®Google Scholar
• Colice GL. Categorizing asthma severity: an overview of national guidelines. Clin Med Res. 2004;2(3):155–163. doi:10.3121/cmr.2.3.155
   PubMedGoogle Scholar
• Dougherty RH, Fahy JV. Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype. Clin Exp Allergy. 2009;39(2):193–202. doi:10.1111/j.1365-2222.2008.03157.x
   PubMed Web of Science ®Google Scholar
• Accordini S, Bugiani M, Arossa W, et al. Poor control increases the economic cost of asthma. A multicentre population-based study. Int Arch Allergy Immunol. 2006;141(2):189–198. doi:10.1159/000094898
   PubMed Web of Science ®Google Scholar
• Accordini S, Corsico AG, Braggion M, et al. The cost of persistent asthma in Europe: an international population-based study in adults. Int Arch Allergy Immunol. 2013;160(1):93–101. doi:10.1159/000338998
   PubMed Web of Science ®Google Scholar
• Rodrigo GJ, Rodrigo C, Hall JB. Acute asthma in adults: a review. Chest. 2004;125(3):1081–1102. doi:10.1378/chest.125.3.1081
   PubMed Web of Science ®Google Scholar
• Serra-Batlles J, Plaza V, Morejón E, Comella A, Brugués J. Costs of asthma according to the degree of severity. Eur Respir J. 1998;12(6):1322–1326. doi:10.1183/09031936.98.12061322
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention; 2020. Available from: https://ginasthma.org/wp-content/uploads/2020/04/GINA-2020-full-report_-final-_wms.pdf. Accessed June, 2020.
   Google Scholar
• Globe G, Martin M, Schatz M, et al. Symptoms and markers of symptom severity in asthma–content validity of the asthma symptom diary. Health Qual Life Outcomes. 2015;13:21. doi:10.1186/s12955-015-0217-5
   PubMed Web of Science ®Google Scholar
• Zervas E, Samitas K, Papaioannou AI, Bakakos P, Loukides S, Gaga M. An algorithmic approach for the treatment of severe uncontrolled asthma. ERJ Open Res. 2018;4(1):00125–2017. doi:10.1183/23120541.00125-2017
   PubMedGoogle Scholar
• Global Initiative for Asthma (GINA). Difficult-to-treat & severe asthma in adolescent and adult patients: diagnosis and management; 2018. Available from: https://ginasthma.org/wp-content/uploads/2019/04/GINA-Severe-asthma-Pocket-Guide-v2.0-wms-1.pdf. Accessed June, 2020.
   Google Scholar
• Griswold SK, Nordstrom CR, Clark S, Gaeta TJ, Price ML, Camargo CA Jr. Asthma exacerbations in North American adults: who are the “frequent fliers” in the emergency department? Chest. 2005;127(5):1579–1586. doi:10.1378/chest.127.5.1579
   PubMed Web of Science ®Google Scholar
• Guilbert TW, Garris C, Jhingran P, et al. Asthma that is not well-controlled is associated with increased healthcare utilization and decreased quality of life. J Asthma. 2011;48(2):126–132. doi:10.3109/02770903.2010.535879
   PubMed Web of Science ®Google Scholar
• Ivanova JI, Bergman R, Birnbaum HG, Colice GL, Silverman RA, McLaurin K. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma. J Allergy Clin Immunol. 2012;129(5):1229–1235. doi:10.1016/j.jaci.2012.01.039
   PubMed Web of Science ®Google Scholar
• Bateman ED, O’Byrne PM, Busse WW, et al. Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone. Thorax. 2014;69(4):312–319. doi:10.1136/thoraxjnl-2013-203600
   PubMed Web of Science ®Google Scholar
• Jackson DJ, Sykes A, Mallia P, Johnston SL. Asthma exacerbations: origin, effect, and prevention. J Allergy Clin Immunol. 2011;128(6):1165–1174. doi:10.1016/j.jaci.2011.10.024
   PubMed Web of Science ®Google Scholar
• O’Byrne PM, Barnes PJ, Rodriguez-Roisin R, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med. 2001;164(8 Pt 1):1392–1397. doi:10.1164/ajrccm.164.8.2104102
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Löfdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med. 1997;337(20):1405–1411. doi:10.1056/NEJM199711133372001
   PubMed Web of Science ®Google Scholar
• National Heart, Lung, and Blood Institute (NHLBI). National Asthma Education and Prevention Program (NAEPP); 2020. Available from: https://www.nhlbi.nih.gov/science/national-asthma-education-and-prevention-program-naepp. Accessed August, 2020.
   Google Scholar
• National Heart, Lung, and Blood Institute (NHLBI). Expert panel report 3: guidelines for the diagnosis and management of asthma; 2007. Available from: https://www.nhlbi.nih.gov/health-topics/guidelines-for-diagnosis-management-of-asthma. Accessed June, 2020.
   Google Scholar
• Suruki RY, Daugherty JB, Boudiaf N, Albers FC. The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA. BMC Pulm Med. 2017;17(1):74. doi:10.1186/s12890-017-0409-3
   PubMed Web of Science ®Google Scholar
• Schatz M, Nakahiro R, Crawford W, Mendoza G, Mosen D, Stibolt TB. Asthma quality-of-care markers using administrative data. Chest. 2005;128(4):1968–1973. doi:10.1378/chest.128.4.1968
   PubMed Web of Science ®Google Scholar
• Raebel MA, Schmittdiel J, Karter AJ, Konieczny JL, Steiner JF. Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases. Med Care. 2013;51(8 Suppl 3):S11–21. doi:10.1097/MLR.0b013e31829b1d2a
   PubMed Web of Science ®Google Scholar
• Schatz M, Meckley LM, Kim M, Stockwell BT, Castro M. Asthma exacerbation rates in adults are unchanged over a 5-year period despite high-intensity therapy. J Allergy Clin Immunol Pract. 2014;2(5):570–574.e1. doi:10.1016/j.jaip.2014.05.002
   PubMed Web of Science ®Google Scholar
• Zeiger RS, Schatz M, Dalal AA, et al. Utilization and costs of severe uncontrolled asthma in a managed-care setting. J Allergy Clin Immunol Pract. 2016;4(1):120–129.e3. doi:10.1016/j.jaip.2015.08.003
   PubMed Web of Science ®Google Scholar
• Davis J, Trudo F, Siddall J, Small M. Burden of asthma among patients adherent to ICS/LABA: a real-world study. J Asthma. 2019;56(3):332–340. doi:10.1080/02770903.2018.1455858
   PubMed Web of Science ®Google Scholar
• Lee LK, Obi E, Paknis B, Kavati A, Chipps B. Asthma control and disease burden in patients with asthma and allergic comorbidities. J Asthma. 2018;55(2):208–219. doi:10.1080/02770903.2017.1316394
   PubMed Web of Science ®Google Scholar
• Stone B, Davis JR, Trudo F, et al. Characterizing patients with asthma who received Global Initiative for Asthma steps 4–5 therapy and managed in a specialty care setting. Allergy Asthma Proc. 2018;39(1):27–35. doi:10.2500/aap.2018.39.4094
   Web of Science ®Google Scholar
• Gibson PG, McDonald VM. Management of severe asthma: targeting the airways, comorbidities and risk factors. Intern Med J. 2017;47(6):623–631. doi:10.1111/imj.13441
   PubMed Web of Science ®Google Scholar
• McDonald VM, Fingleton J, Agusti A, et al. Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report. Eur Respir J. 2019;53(5):1802058. doi:10.1183/13993003.02058-2018
   PubMed Web of Science ®Google Scholar
• Agusti A, Bel E, Thomas M, et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J. 2016;47(2):410–419. doi:10.1183/13993003.01359-2015
   PubMed Web of Science ®Google Scholar
• Pavord ID, Agusti A. Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease. Eur Respir J. 2016;47(5):1299–1303. doi:10.1183/13993003.00055-2016
   PubMed Web of Science ®Google Scholar